Leveraging Device Clinical Data in Great Britain for IVDR Performance Evaluations
One of the challenges being experienced by IVD manufacturers, in meeting the requirements of the IVDR, is ensuring (and…
Resources & News
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 82–90 of 129
IVDD vs IVDR: Greatest Impacts on IVD Manufacturers
The IVDR has brought about a paradigm shift in the regulatory framework for IVDs placed on the…
EU Importation and Taxation Considerations: DDP vs DAP
Asides from the regulatory hurdles necessary to navigate when marketing your devices in the EU, taxation requirements are also…
MDR Clinical Evaluation Reports for Lower-Risk Class Devices
It is known that the main objective of the implementation of the MDR was to strengthen the regulatory framework…
Key Takeaways from RAPS Euro Convergence: Advancing Regulatory Practices
The RAPS Euro Convergence Conference proved to be an exceptional gathering of regulatory professionals, offering an unparalleled level of…
PMPF Under the IVDR: Methods, Justifications, and Triggers
As we have mentioned in…
What is the Difference Between PMS and PMPF Under the IVDR?
While post-market clinical follow-up (PMCF) studies were a concept…
Linking IVDR Performance Evaluations and Risk Management
Similar to…
MDD Declaration of Conformity After 26 May 2021
As a regulatory representative for foreign manufacturers in the EU, UK, US, and Switzerland, MedEnvoy participated in several audits with…
Showing 82–90 of 129